F/m Investments LLC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1834499 WASHINGTON, DC

Position in ANIP

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$220,318

-$5,132,050 QoQ

Shares Held

2,865

-95.8% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

F/m Investments LLC holds $7,982,739 across 4 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	8,384	$4,971,544
2	COLL	Collegium Pharmaceutical, Inc	47,993	$1,587,128
3	XERS	Xeris Biopharma Holdings, Inc.	207,543	$1,203,749
4	ANIP	Ani Pharmaceuticals Inc This page	2,865	$220,318

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$220,318	2,865	-95.8%	Shares	Sole	2026-05-11
2025-12-31	$5,352,368	67,803	+21.0%	Shares	Sole	2026-02-03
2025-09-30	$5,134,180	56,050	-2.0%	Shares	Sole	2025-11-13
2025-06-30	$3,731,973	57,195	+0.2%	Shares	Sole	2025-08-13
2025-03-31	$3,821,104	57,074	+1.4%	Shares	Sole	2025-05-14
2024-12-31	$3,112,982	56,313	-8.9%	Shares	Sole	2025-02-13
2024-09-30	$3,685,913	61,782	—	Shares	Defined	2024-10-29
No filing history on record for this holder in this stock.